Sangeetha S, Divya N, Kumar S, Ar S, Chandrika R
Iran J Child Neurol. 2024; 18(4):47-60.
PMID: 39478943
PMC: 11520275.
DOI: 10.22037/ijcn.v18.43364.
V S, Pattanaik A, Marate S, Mani R, Pai A, Mukhopadhyay C
Neurol Res Pract. 2024; 6(1):21.
PMID: 38600592
PMC: 11008014.
DOI: 10.1186/s42466-024-00315-6.
Labbad I, Shammas I, Abbas A, Alorfhli I, Agha M
Ann Med Surg (Lond). 2023; 85(6):3166-3170.
PMID: 37363509
PMC: 10289577.
DOI: 10.1097/MS9.0000000000000841.
Mohammed F, Al-Kumaim N, Alzahrani A, Fazea Y
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767142
PMC: 9914293.
DOI: 10.3390/ijerph20031775.
Duong-Quy S, Huynh-Truong-Anh D, Tran-Xuan Q, Nguyen-Quang T, Nguyen-Thi-Kim T, Nguyen-Chi T
Front Cardiovasc Med. 2023; 9:1035896.
PMID: 36741850
PMC: 9892716.
DOI: 10.3389/fcvm.2022.1035896.
COVID-19 Associated Guillain-Barré Syndrome: A Report of Nine New Cases and a Review of the Literature.
Ivan A, Odajiu I, Popescu B, Davidescu E
Medicina (Kaunas). 2022; 58(8).
PMID: 35893091
PMC: 9332472.
DOI: 10.3390/medicina58080977.
Changes in ganglioside antibody positivity rates during the COVID-19 pandemic.
Racke M, Niles J, Lorenz R, Kaufman H
J Neuroimmunol. 2022; 367:577877.
PMID: 35490444
PMC: 9023361.
DOI: 10.1016/j.jneuroim.2022.577877.
Case Report: Isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination.
Kubota T, Hasegawa T, Ikeda K, Aoki M
F1000Res. 2022; 10:1142.
PMID: 35444796
PMC: 8990240.
DOI: 10.12688/f1000research.74299.2.
Neuroimmune disorders in COVID-19.
Arino H, Heartshorne R, Michael B, Nicholson T, Vincent A, Pollak T
J Neurol. 2022; 269(6):2827-2839.
PMID: 35353232
PMC: 9120100.
DOI: 10.1007/s00415-022-11050-w.
COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.
Taga A, Lauria G
J Peripher Nerv Syst. 2022; 27(1):4-30.
PMID: 35137496
PMC: 9115278.
DOI: 10.1111/jns.12482.
Guillain-Barré Syndrome in the COVID-19 Pandemic.
Tawakul A, Al-Doboke A, Altayyar S, Alsulami S, Alfahmi A, Nooh R
Neurol Int. 2022; 14(1):34-48.
PMID: 35076589
PMC: 8788454.
DOI: 10.3390/neurolint14010003.
Relevance of CSF, Serum and Neuroimaging Markers in CNS and PNS Manifestation in COVID-19: A Systematic Review of Case Report and Case Series.
Podury S, Srivastava S, Khan E, Kakara M, Tandon M, Shrestha A
Brain Sci. 2021; 11(10).
PMID: 34679418
PMC: 8533964.
DOI: 10.3390/brainsci11101354.
COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series.
Elzouki A, Osman M, Ahmed M, Al-Abdulmalek A, Altermanini M, Al-Ani H
Travel Med Infect Dis. 2021; 44:102169.
PMID: 34624553
PMC: 8492388.
DOI: 10.1016/j.tmaid.2021.102169.
Treatment Options for COVID-19-Related Guillain-Barré Syndrome: A Systematic Review of Literature.
Goudarzi S, Esmaeeli S, Valencia J, Lu M, Hales R, Fehnel C
Neurologist. 2021; 26(5):196-224.
PMID: 34491938
PMC: 8423032.
DOI: 10.1097/NRL.0000000000000342.
Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barré Syndrome.
Kakumoto T, Kobayashi S, Yuuki H, Kainaga M, Shirota Y, Hamada M
Intern Med. 2021; 60(21):3477-3480.
PMID: 34433712
PMC: 8627825.
DOI: 10.2169/internalmedicine.7355-21.
Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.
Koike H, Chiba A, Katsuno M
Neurol Ther. 2021; 10(2):523-537.
PMID: 34117994
PMC: 8196284.
DOI: 10.1007/s40120-021-00261-4.
[Guillain-Barré syndrome as a probable first symptom of severe acute respiratory syndrome Coronavirus 2 in an elderly patient].
Pujol Lucas C, Lobaco Soler M, Roca Rabionet C, Alfonso Martin S, Aragones Pascual J, Espaulella I Panicot J
Rev Esp Geriatr Gerontol. 2021; 56(4):252-253.
PMID: 34116803
PMC: 8075842.
DOI: 10.1016/j.regg.2021.03.003.
Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.
Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A
Can J Neurol Sci. 2021; 49(1):38-48.
PMID: 33949300
PMC: 8267336.
DOI: 10.1017/cjn.2021.102.
Cerebrospinal fluid in COVID-19: A systematic review of the literature.
Lewis A, Frontera J, Placantonakis D, Lighter J, Galetta S, Balcer L
J Neurol Sci. 2021; 421:117316.
PMID: 33561753
PMC: 7833669.
DOI: 10.1016/j.jns.2021.117316.
Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence.
Abdullahi A, Acaroz Candan S, Soysal Tomruk M, Elibol N, Dada O, Truijen S
Front Neurol. 2021; 11:566308.
PMID: 33519663
PMC: 7838680.
DOI: 10.3389/fneur.2020.566308.
